Petra Pharma

About:

Petra Pharma is a clinical-stage pharmaceutical company developing a diverse portfolio of novel therapies.

Website: http://petrapharmacorp.com/

Top Investors: Eli Lilly, AbbVie, ARCH Venture Partners, WuXi AppTec, Empire State Development

Description:

Petra Pharma is a clinical-stage pharmaceutical company developing a diverse portfolio of novel therapies for serious medical conditions such as cancer and metabolic diseases. The company also focused on novel enzyme targets that play a central role in a variety of important cellular processes, including cell division, growth, trafficking, and signaling. It will develop novel small molecules for the treatment of cancer and metabolic diseases to target these cellular processes in order to therapeutically impact human health. Petra Pharma was founded in 2016 and is headquartered in New York, USA.

Total Funding Amount:

$75.5M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

New York, New York, United States

Founded Date:

2016-01-01

Contact Email:

info(AT)petrapharmacorp.com

Founders:

Lewis C. Cantley, Nathanael Gray

Number of Employees:

11-50

Last Funding Date:

2020-04-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai